lobbying_activities: 1182242

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1182242	aeddcfc6-144d-4d58-b0c6-6491cc21527f	Q4	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	3457	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	2011	fourth_quarter	PHA	H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions. Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on dietary supplements, long-acting opiods, Prescription Drug User Fee Act presentation at FDA public meeting. Communications with the National Institute for Occupational Safety and Health (NIOSH) on their proposed list of hazardous drugs for 2012. Support for S. 1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authority.	Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		250000	0	0	2012-01-06T14:56:12-05:00